Commentary on "Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial"

被引：0
|
作者：
Poh, Sharon S. [1 ,2 ]
Wee, Joseph T. S. [1 ,2 ]
机构：
[1] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore 169610, Singapore
[2] Duke NUS Med Sch, Oncol Acad Clin Program, Singapore, Singapore
来源：
CHINESE CLINICAL ONCOLOGY | 2022年
关键词：
NASOPHARYNGEAL CARCINOMA; MRI;
D O I：
10.21037/cco-22-73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
    Hirsch, L.
    Le Tourneau, C.
    ONCOLOGIE, 2017, 19 (1-2) : 44 - 46
  • [32] Comment on "Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial"
    Ferreira, Daniel
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (03) : 263 - 264
  • [33] Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial
    Linares-Espinos, Estefania
    Sanchez-Salas, Rafael
    EUROPEAN UROLOGY, 2019, 75 (01) : 199 - 199
  • [34] Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial
    Giannarini, Gianluca
    Crestani, Alessandro
    Ficarra, Vincenzo
    EUROPEAN UROLOGY, 2018, 74 (06) : 840 - 841
  • [35] Outpatient elective induction of labour at 39 weeks' gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial
    Nicholson, Sarah M.
    Flood, Karen
    Dicker, Patrick
    Molphy, Zara E.
    Smith, Orla T.
    Oprescu, Corina I.
    Wall, Eimear M.
    Nimr, Sara N. El
    Shanahan, Ita M.
    Kennedy, Bernard J.
    V. Daly, Ronan
    Gannon, Geraldine
    Looi, Claudia
    Fernandez, Elena
    Malone, Fergal D.
    ECLINICALMEDICINE, 2024, 74
  • [36] Appendectomy versus non-operative treatment for acute uncomplicated appendicitis in children: study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial
    Hall, Nigel J.
    Eaton, Simon
    Abbo, Olivier
    Arnaud, Alexis P.
    Beaudin, Marianne
    Brindle, Mary
    Butter, Andreana
    Davies, Dafydd
    Jancelewicz, Tim
    Johnson, Kathy
    Keijzer, Richard
    Lapidus-Krol, Eveline
    Offringa, Martin
    Piche, Nelson
    Rintala, Risto
    Skarsgard, Erik
    Svensson, Jan F.
    Ungar, Wendy J.
    Wester, Tomas
    Willan, Andrew R.
    Zani, Augusto
    St Peter, Shawn D.
    Pierro, Agostino
    BMJ PAEDIATRICS OPEN, 2017, 1 (01)
  • [37] Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
    Phillips, Richard O.
    Robert, Jerome
    Abass, Kabiru Mohamed
    Thompson, William
    Sarfo, Fred Stephen
    Wilson, Tuah
    Sarpong, Godfred
    Gateau, Thierry
    Chauty, Annick
    Omollo, Raymond
    Otieno, Michael Ochieng
    Egondi, Thaddaeus W.
    Ampadu, Edwin O.
    Agossadou, Didier
    Marion, Estelle
    Ganlonon, Line
    Wansbrough-Jones, Mark
    Grosset, Jacques
    Macdonald, John M.
    Treadwell, Terry
    Saunderson, Paul
    Paintsil, Albert
    Lehman, Linda
    Frimpong, Michael
    Sarpong, Nanaa Francisca
    Saizonou, Raoul
    Tiendrebeogo, Alexandre
    Ohene, Sally-Ann
    Stienstra, Ymkje
    Asiedu, Kingsley B.
    van der Werf, Tjip S.
    LANCET, 2020, 395 (10232): : 1259 - 1267
  • [38] Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
    Vermorken, Jan B.
    Stoelmacher-Williams, Jan
    Davidenko, Irina
    Licitra, Lisa
    Winquist, Eric
    Villanueva, Cristian
    Foa, Paolo
    Rottey, Sylvie
    Skladowski, Krzysztof
    Tahara, Makoto
    Pai, Vasant R.
    Faivre, Sandrine
    Blajman, Cesar R.
    Forastiere, Arlene A.
    Stein, Brian N.
    Oliner, Kelly S.
    Pan, Zhiying
    Bach, Bruce A.
    LANCET ONCOLOGY, 2013, 14 (08): : 697 - 710
  • [39] Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial
    de Jonge, Nick A.
    Sikkens, Jonne J.
    Zweegman, Sonja
    Beeker, Aart
    Ypma, Paula
    Herbers, Alexandra H.
    Vasmel, Wies
    de Kreuk, Arne
    Coenen, Juleon L. L. M.
    Lissenberg-Witte, Birgit
    Kramer, Mark H. H.
    van Agtmael, Michiel A.
    Janssen, Jeroen J. W. M.
    LANCET HAEMATOLOGY, 2022, 9 (08): : E563 - E572
  • [40] Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
    Yau, Thomas
    Park, Joong-Won
    Finn, Richard S.
    Cheng, Ann-Lii
    Mathurin, Philippe
    Edeline, Julien
    Kudo, Masatoshi
    Harding, James J.
    Merle, Philippe
    Rosmorduc, Olivier
    Wyrwicz, Lucjan
    Schott, Eckart
    Choo, Su Pin
    Kelley, Robin Kate
    Sieghart, Wolfgang
    Assenat, Eric
    Zaucha, Renata
    Furuse, Junji
    Abou-Alfa, Ghassan K.
    El-Khoueiry, Anthony B.
    Melero, Ignacio
    Begic, Damir
    Chen, Gong
    Neely, Jaclyn
    Wisniewski, Tami
    Tschaika, Marina
    Sangro, Bruno
    LANCET ONCOLOGY, 2022, 23 (01): : 77 - 90
12345